Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nihon Kohden Corporation ( (JP:6849) ) just unveiled an update.
Nihon Kohden Corporation has disclosed the progress of its previously announced share buyback program, reporting that it repurchased 718,200 common shares for a total of 1,107,823,500 yen between December 4 and December 31, 2025, via ToSTNeT-3 transactions on the Tokyo Stock Exchange. This buyback is part of a broader board-approved program authorizing the acquisition of up to 3.8 million shares, or 2.33% of outstanding shares excluding treasury stock, for as much as 5 billion yen by March 31, 2026, signaling ongoing efforts to enhance capital efficiency and shareholder returns through active balance sheet management.
The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1798.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Prime Market of the Tokyo Stock Exchange, known for developing and supplying a wide range of diagnostic and patient-monitoring equipment to hospitals and healthcare providers in Japan and overseas.
Average Trading Volume: 602,210
Technical Sentiment Signal: Buy
Current Market Cap: Yen281B
For an in-depth examination of 6849 stock, go to TipRanks’ Overview page.